跳至主要内容
临床试验/IRCT2016053028165N1
IRCT2016053028165N1已完成2 期

Effect of curcumin supplementation on iron overload, oxidative stress and insulin resistance in patients with beta thalassemia major

ational Nutrition and Food Technology Research Institute0 个研究点目标入组 64 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 40 years(—)
性别
All

入选标准

  • age between 18 and 40, Regular blood transfusions based on prescription, consumption of deferoxamine as an iron chelator drug, Not taking any nutritional supplements from 3 months before the start of the study, patients without hepatitis B, C, HIV and chronic kidney and heart diseases, not using other chelator medication except deferoxamine.
  • Excluson criteria: A significant change in dose of deferoxamine therapy during the study, using another iron chelator drug in addition to deferoxamine and pregnancy

排除标准

  • 未提供

研究者

发起方
ational Nutrition and Food Technology Research Institute

相似试验